Serum IGF1, IGF2 and IGFBP3 and risk of advanced colorectal adenoma-Reference-Cited by-同舟云学术

Serum IGF1, IGF2 and IGFBP3 and risk of advanced colorectal adenoma

Published:2011-11-02 Issue:2 Volume:131 Page:E105-E113
ISSN:0020-7136
Container-title:International Journal of Cancer
language:en
Short-container-title:Int. J. Cancer

Author:

Gao Ying,Katki Hormuzd,Graubard Barry,Pollak Michael,Martin Michael,Tao Yuzhen,Schoen Robert E.,Church Timothy,Hayes Richard B.,Greene Mark H.,Berndt Sonja I.

Publisher

Wiley

Subject

Cancer Research,Oncology

Reference46 articles.

1. Insulin and insulin-like growth factor signalling in neoplasia;Pollak;Nat Rev Cancer,2008

2. Control of growth by the somatropic axis: growth hormone and the insulin-like growth factors have related and independent roles;Butler;Annu Rev Physiol,2001

3. Insulin-like growth factor-binding proteins in serum and other biological fluids: regulation and functions;Rajaram;Endocr Rev,1997

4. Phosphatidylinositol 3-kinase and Akt protein kinase mediate IGF-I- and prosaptide-induced survival in Schwann cells;Campana;J Neurosci Res,1999

5. Epidermal growth factor (EGF) and somatomedin C regulate G1 progression in competent BALB/c-3T3 cells;Leof;Exp Cell Res,1982

Cited by 50 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Improved overall survival in patients developing endocrine toxicity during treatment with nivolumab for advanced non-small cell lung cancer in a prospective study;Journal of Endocrinological Investigation;2024-04-29

2. Circulating Adipocytokines and Insulin Like-Growth Factors and Their Modulation in Obesity-Associated Endometrial Cancer;Cancers;2024-01-26

3. Autocrine IGF-II-Associated Cancers: From a Rare Paraneoplastic Event to a Hallmark in Malignancy;Biomedicines;2023-12-22

4. A systematic review and meta-analysis for the association of the insulin-like growth factor1 pathway genetic polymorphisms with colorectal cancer susceptibility;Frontiers in Oncology;2023-05-22

5. Identification and validation of a prognostic risk-scoring model based on sphingolipid metabolism-associated cluster in colon adenocarcinoma;Frontiers in Endocrinology;2022-11-28